Advertisement

Maligne Tumoren der Leber und Gallenwege

  • S. W. Sahm
  • M. Lorenz

Zusammenfassung

Maligne Tumoren der Leber können primär im Organ oder den topographisch zugeordneten Strukturen der Gallenwege entstehen oder sekundär als Metastasen von Tumoren anderer Organe die Leber befallen. Die Malignome der extrahepatischen Gallenwege (extrahepatische Gallengänge, Gallenblase, Papilla Vateri) werden wegen ihrer engen Beziehung zur Leber ebenfalls hier berücksichtigt. Komplikationen wie etwa eine Cholestase sind nicht selten Folge dieser formal extrahepatischen Prozesse.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215:31–38PubMedCrossRefGoogle Scholar
  2. Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19:311–322PubMedCrossRefGoogle Scholar
  3. Bobbio-Pallavicini E, Porta C, Moroni M, Bertulezzi G, Civelli L, Pugliese P, Nastasi G (1997) Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study. Eur J Cancer 33:1785–1788CrossRefGoogle Scholar
  4. Caselmann WH, Blum HE, Fleig WE, Huppert PE, Ramadori G, Schirmacher P, Sauerbruch T (1999) Leitlinien der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten zur Diagnostik und Therapie des hepatozellulären Karzinoms. Z Gastroenterol 37:353–365PubMedGoogle Scholar
  5. Dienes HP (1998) Häufigkeit und Klassifikation von primären Lebertumoren. In: Deutsche Gesellschaft für Verdauungs-und Stoffwechselkrankheiten. Arbeitsgemeinschaft Gastroenterologische Onkologie. Lebertumore, Hannover. 16–20Google Scholar
  6. Dusheiko GM, Hobbs KEF, Dick R, Burroghs AK (1992) Treatment of small hepatocellular carcinomas. Lancet 340:285–288PubMedCrossRefGoogle Scholar
  7. Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Eng J Med 341:1368–1378CrossRefGoogle Scholar
  8. Groupe d’etude et de traitment du carcinome hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261CrossRefGoogle Scholar
  9. Hermanek P, Sobin LH (Hrsg) (1992) UICC TNM classification of malignant tumors, 4th edn. Springer, BerlinGoogle Scholar
  10. Herrmann R, Orth B, Neuhaus P (1994) Gallenblasen-und Gallengangkarzinom. In: Wilmanns W, Huhn D, Wilms K (Hrsg) Internistische Onkologie. Thieme, Stuttgart New York, S 543–547Google Scholar
  11. Ishii H, Okada S, Okusaka T Yoshimori M, Nakasuka H, Shimada K, Yamasaki S, Nakanishi Y, Sakamato M (1998) Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 82:1638–42PubMedCrossRefGoogle Scholar
  12. Koito K, Namieno T, Ichimura T, Hirokawa N, Syonai T, Hareyama M, Katsuramaki T, Hirata K, Nishi M (2000) Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with arterial embolization or percutaneous ethanol injection therapy. Am Roentgenol 174:337–41Google Scholar
  13. Kojiro M, Nakashima O (1999) Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 19:287–296PubMedCrossRefGoogle Scholar
  14. Kudo M (1999) Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 19:297–309PubMedCrossRefGoogle Scholar
  15. Lake JR (1993) Benign and malignant neoplasms of the gallbladder, bile ducts, and ampulla. In: Sleisenger MH, Fordtran JS (Hrsg) Gastrointestinal disease: pathophysiology, diagnosis, management, 5th edn. WB Saunders, Philadelphia, S 1891–1901Google Scholar
  16. Livraghi T, Giorgio A, Marin G, et al., (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101–108PubMedGoogle Scholar
  17. Livraghi T, Goldberg SN, Lazzaroni S (1999) Radiofrequency ablation vs. ethanol injection in the treatment of small hepatocellular carcinoma. Radiology 210:655–661PubMedGoogle Scholar
  18. Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semi Liver Dis 19:329–338CrossRefGoogle Scholar
  19. Lorenz M, Liermann D, Staib-Sebler E, Gog C, Encke A, Kollath J (1994) Noradrenalingestützte selektive Chemoembolisation von hepatozellulären Karzinomen. Zentralbl Chir 119:777–786PubMedGoogle Scholar
  20. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699PubMedCrossRefGoogle Scholar
  21. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 334:1561–1567PubMedCrossRefGoogle Scholar
  22. Okada S (1999) Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 19:323–328PubMedCrossRefGoogle Scholar
  23. Okuda K, Ohtuiki T, Obata H, et al. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56:918PubMedCrossRefGoogle Scholar
  24. Okuda K, Kojiro M, Okuda H (1993) Neoplasms of the liver. In: Schiff L, Schiff ER (Hrsg) Diseases of the liver, 7th edn. JB Lippincott, Philadelphia, S 1236–1296Google Scholar
  25. Onishi K, Yoshioka H, Ito S, Fujiwara K (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:67–72CrossRefGoogle Scholar
  26. Ormann, W (1993) Das fibrolamelläre hepatozelluläre Karzinom. Leber Magen Darm 23:128–131PubMedGoogle Scholar
  27. Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, Müller JM, Hortnagl H, Lochs H (1998) Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114:536–542PubMedCrossRefGoogle Scholar
  28. Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D (1997) Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 35:1059–1067PubMedGoogle Scholar
  29. Scheithauer W, Heijna M (1995) Hepatocellular carcinoma. Oncology 18:327–332CrossRefGoogle Scholar
  30. Tsukuma H, Hiyama T, Tanaka S, et al., (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797–1801PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • S. W. Sahm
  • M. Lorenz

There are no affiliations available

Personalised recommendations